Newcastle disease virus vectored herpesvirus vaccines
AssigneeMerial Limited
InventorsMichel Bublot, Frederic Reynard, Herve Poulet, Frederic Raymond David
Life of this patent
Estimating the term…
Abstract
The present invention encompasses recombinant Newcastle Disease Virus-Herpesvirus vaccines or compositions. The invention encompasses recombinant NDV vectors encoding and expressing herpesvirus pathogen, antigens, proteins, epitopes or immunogens. Such vaccines or compositions can be used to protect animals against disease.
Claims16
A composition comprising:
- (i) a recombinant Newcastle Disease Virus (NDV) vector, wherein the NDV vector comprises a genome having the sequence as set forth in SEQ ID NO:27, and
- (ii) a pharmaceutically or veterinarily acceptable carrier;
- wherein the recombinant NDV vector further comprises a first heterologous polynucleotide encoding a feline Herpesvirus glycoprotein B (gB) and a second heterologous polynucleotide encoding a feline Herpesvirus glycoprotein D (gD) inserted into said genome.
A recombinant NDV vector, wherein said NDV vector comprises a genome having the sequence as set forth in SEQ ID NO:27, wherein said vector further comprises two polynucleotides encoding a feline Herpesvirus glycoprotein B (gB) and a feline Herpesvirus glycoprotein D (gD).
Dependencies are inferred from the claim text.